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 SAŽETAK 
 
Glija je vrlo heterogena populacija sastavljena od vrlo različitih stanica koje zajedno 
sudjeluju u održavanju homeostaze središnjeg živčanog sustava (SŽS). Dugo se smatralo 
da se radi o acelularnom vezivnom tkivu, dok je danas to gledište u potpunosti odbačeno 
te je sve više istraživanja usmjereno prema glijalnim stanicama. Zahvaljujući tehnološkom 
napretku, otkrivaju se nove posebitosti u funkciji tih stanica te njihovoj interakciji kako s 
neuronima, tako i međusobno. Tijekom razvoja SŽS, radijalne glije vode migraciju 
neurona, NG2 stanice primaju informacije od neurona i inhibiraju aksonalni rast, 
oligodendrociti formiraju mijelin, astrociti formiraju krvno-moždanu barijeru (KMB) i 
reguliraju optimalne uvjete poput pH, ionskog gradijenta, reapsorpcije neurotransmitera. 
Nadalje, ependimalne stanice formiraju cerebrospinalni fluid (CSF) i štite SŽS, a mikroglija 
uklanjaju neželjene stanice. U patološkim uvjetima glijalne stanice djeluju s imunosnim 
sustavom i otpuštaju neurotrofičke faktore. Međutim, mnogo još preostaje neobjašnjeno, 
a već i sama identifikacija i karakterizacija glija predstavljaju izazov. Glijalne stanice se 
razlikuju po morfologiji, biokemiji i funkcijama. Za njihovu identifikaciju se najčešće koriste 
eksprimirane molekule na staničnoj membrani, proteini citoskeleta ili signalne molekule 
poput faktora rasta, neurotrofičkih faktora, hormona i citokina koje otpuštaju. Identifikacija 
nailazi na probleme jer ne postoji dovoljno markera koji mogu sa sigurnošću odrediti 
(pod)tipove glija zbog toga što mnoge markere ko-eksprimiraju različite stanice živčanog 
sustava. Ko-ekspresija i heterogenost često vodi prema svrstavanju (pod)tipova glija u istu 
kategoriju. Cilj ovog rada je sakupiti istraživanja provedena na glijalnim stanicama SŽS i 
usporediti različite stavove i pronalaske kroz povijest uz kritički osvrt. Ovaj rad se 
usredotočuje na karakterizaciju i identifikaciju tipova glijalnih stanica te usporedbi 
međusobnih sličnosti i razlika. Označavanje glijalnih stanica pomoću antitijela, kao 
najpopularnija metoda identifikacije je analizirana prema korištenim markerima poput 
GFAP, S100β, Nestin, NG2, Iba1 i sl. te su navedene njihove prednosti i nedostatci. Kako 
su glije ključan dio središnjeg živčanog sustava u zdravim i patološkim uvjetima, više 
istraživanja treba biti usmjereno prema njima. Istraživanja bi se trebala proširiti i na ljude 
i opisati posebne vrste glija primata, još nepoznatih funkcija. 
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 SUMMARY 
 
Glia is a very heterogeneous cell population comprised of very different cells that 
work together to maintain central nervous system (CNS) homeostasis. Long believed role 
of glia being the acellular connective tissue has been overturned, and they have become 
focus of intense research. Due to the technological advances, new functions are being 
discovered, as well as interactions of glia with neurons and the glia between themselves. 
During CNS development, radial glia guide neuronal migration, NG2 receive neuronal 
inputs and inhibit axonal growth, oligodendrocytes myelinate axons, astrocytes form the 
blood-brain-barrier (BBB) and regulate optimal conditions, such as pH, ion gradient, 
neurotransmitter reuptake. Moreover, ependymal cells form cerebrospinal fluid (CSF) and 
protect CNS, while microglia remove unwanted cells. In pathological conditions, glia 
interact with immune system and release neurotrophic factors. However, many issues 
remain to be addressed, because identification and characterization of glia still represents 
a challenge. Glia differ in morphology, biochemistry and functions. They are most 
commonly identified by expressed molecules on cell membrane, cytoskeletal proteins or 
signal molecules, such as growth factors, neurotrophic factors, hormones or cytokines they 
release. Identification presents a problem because there is an insufficient amount of 
markers that can specifically identify a particular glial (sub)type because the markers are 
often co-expressed by several cell types of the nervous system. Co-expression and 
heterogeneity of glial (sub)types often lead to assignment of the same category. The aim 
of this work is to bring together the research conducted on CNS glia and to compare 
different opinions and findings throughout the history, critically remarking the research. 
This work focuses on characterization and identification of neuroglia types and pointing out 
the similarities and differences among them. Most commonly used immunostaining 
markers, for example, GFAP, S100β, Nestin, NG2 and Iba1 are analyzed with their 
advantages and weaknesses regarding specificity. As the glia are vital part of CNS in both 
healthy and pathological conditions, more research should be directed to them. Research 
should also involve humans and depict unique primate glia, with still unknown functions. 
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1. NEUROGLIA AT A GLANCE 
 
From the first time R. Virchow described neuroglia in 1856, it was set 
against the neurocentric concept of nervous elements: 
‘Hitherto, gentlemen, in considering the nervous system, I have only 
spoken of the really nervous parts of it. But if we would study the 
nervous system in its real relations in the body, it is extremely 
important to have a knowledge of that substance also which lies 
between the proper nervous parts, holds them together and gives the 
whole its form in a greater or less degree’ [1]. 
He publicly broadcasted that glia is a connective tissue, but also 
highlighted the importance of studying the nervous system for the real 
relations. Even though the focus has been on neurons, a change in the 
perspective has been made and recently more research has been oriented 
towards the glia. As a result, glia were found to be remarkably 
heterogeneous cell population with variety of functions, and still a lot 
remains to be unveiled. 
(Neuro)glia are non-neuronal CNS cell lineages of different origin, 
morphology, physiological and functional features [2]. They are often 
described as non-excitable nervous cells, but exceptions exist. The main 
function of neuroglia could be summarized as maintenance of the 
homeostasis of the nervous system. 
Neuroglia can be divided into two main categories: central nervous 
system (CNS) and peripheral nervous system (PNS) glia. The CNS glia is 
subdivided into microglia and macroglia (Figure 1). Microglia originate from 
the yolk-sac progenitors in mesoderm that populate the brain during 
development [3]. They have defensive role in the nervous system and 
detect and phagocytose damaged neurons, synapses, and plaques [4]. 
Macroglia originate from precursors in the neurogenic region of the 
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ectoderm. Neural stem cells give rise to radial glia or neurons, depending 
on the extracellular signals [5]. Radial glia further differentiate into 
astrocytes, ependymal cells and NG2 glia, which precede oligodendrocytes. 
Astrocytes support neurons structurally, metabolically and trophically. 
Furthermore, they take part in formation of the blood-brain barrier, 
absorption of neurotransmitters and extracellular fluid homeostasis. They 
participate in synapse formation, maturation and activity and also form glial 
scar as a result of brain infection or injury [6]. Ependymal cells protect the 
CNS by forming a cellular barrier between blood and cerebrospinal fluid. 
They form a CSF stream with plentiful cilia, filter molecules and debris [7]. 
NG2 cells are abundant in proteoglycan NG2. Some cells positive for this 
proteoglycan are positive for glial fibrillary acidic protein (GFAP), while other 
NG2 positive cells are positive for ganglioside receptors, present in neurons. 
Therefore, proteoglycan NG2 was named “nerve/glial antigen 2” for being 
in cells with properties of both neurons and glia, while NG2 cells got their 
name for the proteoglycan. NG2 cells have shown potential to differentiate 
into several types of glial cells, but also into neurons [8]. They receive 
inputs from neurons and inhibit axonal growth and support formation of 
glial scar [9] [10]. Oligodendrocytes produce myelin sheaths to increase the 
velocity of impulses that propagate along axons. Because of (enormous) 
heterogeneity of glia, researchers hold different opinions and approaches to 
identify and classify the glia (Figure 1). The classification of the macroglia 
types is still under debate. Some researchers classify ependymal cells as 
the individual macroglia subcategory, while others classify ependymal cells 
as subtype of astrocytes [11]. NG2 cells are also in some articles considered 
to be macroglia category, while in others are positioned alongside 
oligodendrocytes, as their precursors. They show various vital functions in 
the CNS, requesting for further examination. 
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Figure 1. Classification of CNS glia. A shows NG2 as individual macroglia category, 
while ependymal cells are classified as a subtype of astrocytes (image taken and 
modified from [2]). B shows ependymal cells as individual category (image taken 
and modified from [12]). C shows NG2 as an individual category (image taken and 
modified from [13]). 
 
As neuroglia perform very diverse functions and are involved in 
various neural activities, their division is based on their structural and 
biochemical characteristics. Drawback to identification of glia is that a 
number of molecules are co-expressed on different glial cells but also by 
A 
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neurons. This potentially leads to misinterpretation and considerably 
reduces the number of reliable molecular markers. 
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2. NEUROGLIA EVOLUTION 
 
 
Glial appearance began most likely when central nervous system 
(CNS) began to centralize and started to form ganglia, as well as peripheral 
sensory organs. 
The first organisms in which the proto-neuroglia was found were 
Nematodes. Roundworm Caenorhabditis elegans’ nervous system is made 
of 302 neurons and 50 supportive cells of ectodermal origin and six 
supportive cells of mesodermal origin. 46 of the supportive cells are 
associated with sensory organs. The remaining four cells are known to 
compose cephalic sheath and associate with neural ring. These supportive 
cells are the proto-astrocytes [2]. The ancestral glial cells in C. elegans 
enwrap synapses, are possibly involved in ion homeostasis, and contribute 
to nervous system development; however, the functions still are not fully 
elucidated [2] [14]. 
It wasn’t until Arthropoda that neuroglia became indispensable for 
neuronal survival (Figure 2). In the Drosophila melanogaster, glial cells 
comprise approximately 10% of total number of CNS cells. They are divided 
into classes of wrapping glia of the PNS and surface glia that form 
hemolymph-brain barrier. Glial cells regulate ion control, keep the 
neurotransmitter and metabolic homeostasis, ensheath axons and mount 
astrogliotic reactions to phagocytosis in case of pathologic state [2] [14]. 
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Figure 2. Evolution of glia (image taken from [2]). 
 
 
In addition to the already developed ancestral microglia, ancestral 
myelin sheath and further glial diversification in Echinoderms, radial glia 
occurred, which led to brain gaining the layered structure. By an increase 
of the brain thickness, the brain parenchymal glia started to develop and 
gradually became predominant type of astrocytes that maintain the 
homeostasis of mature brain in higher vertebrates. Radial glia, on the other 
hand, in higher vertebrates are present only during embryonic development 
and not in the mature brain [14] [2]. 
As the brain size enlarged, glia grew in quantity and diversity. In 
mammals, radial glia are limited to embryonic development and are present 
in radial-like cells in retina, in cerebellum, in hypothalamus and in 
subventricular zone (SVZ). Human astrocytes are the most complex 
comparing to rodents, dogs or felines. The human protoplasmic astrocytes 
are more than two times larger than rats’, process 10 times more 
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information and possess twofold complexity of arborisation. Humans also 
have several unique types of astroglia [2] [14]. 
Quantity of glia varies considerably among species. By increase in the 
cerebral cortex mass, glial number increases, even though the trend is not 
applicable to all species. Vertebrates follow the glia to neuron ratio 
positively by enlargement of brain. The adult human brain averages 1.5 kg 
and has 86 billion neurons and 85 billion non-neuronal cells, including glial 
cells, pericytes, fibroblasts and endothelial cells [15]. 
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3. GLIOGENESIS 
 
Gliogenesis is the process by which glial cells are derived from 
multipotent neural stem cells (NSC) during the embryonic development. 
NSC, also known as neuroepithelial cells (Figure 3); develop into radial glia, 
one of first specialized cells in the CNS, distinct by their bipolar shape [16]. 
Neuronal and glial lineages appear by asymmetric division of radial glia, as 
a result of extrinsic signals [5]. 
During the embryonic development of the CNS, radial glia are the 
leading population that encodes positional cues required for neuron 
formation, guidance, survival and maintenance [17]. They differentiate into 
ependymal cells, astrocytes, NG2 glia leading to oligodendrocytes. 
Astrocytes promote NSC differentiation by BMP ligands and signaling. 
Ependymal cells can also modulate BMP signaling to promote generation of 
NG2 cells [18]. Additionaly, astrocytes express Notch receptors [19]. Notch 
signals inhibit neuronal differentiation but enhance glial generation and 
differentiation [5]. 
 
 
Figure 3. Development of V-SVZ astrocytes (image taken from [17]). 
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4. TRIPARTITE SYNAPSE 
 
It is widely accepted that signal transmission in the nervous system 
occurs through synapses. In the terminal parts of pre-synaptic axon, 
numerous synaptic vesicles are filled with neurotransmitters. 
Neurotransmitters are released into the synaptic cleft, where they travel to 
the dendrites of the post-synaptic neurons. Special receptors and channels 
of the post-synaptic neurons uptake the signaling molecules. 
Current research shows that glial cells also take part in synaptic 
neurotransmission. Astroglia regulate synaptic connectivity, strength and 
plasticity and provide for spatial specificity of synaptic inputs. Astrocyte 
processes create a physical barrier, contain transporters that remove 
neurotransmitters from synaptic cleft (glutamate, GABA and adenosine, 
etc.), and modulate the action potential-evoked synaptic transmission [2]. 
For example, reuptake of glutamate is particularly important because it is 
an excitatory neurotransmitter that in higher concentration damages or kills 
neurons, among other cells. Nevertheless, neurons need glutamate for 
various functions, but cannot synthetize it de novo. Astrocytes reuptake 
large quantities of glutamate from the cleft and release it in different ways. 
The most important is the glutamate-glutamine shuttle (Figure 4). 
Conversion of glutamate to glutamine, at the cost of one ATP, involves 
enzyme glutamine synthetase (GS). Glutamine is transported to neurons by 
specific transporters and hydrolyzed back into glutamate in presynaptic 
neuron [20]. 
The mechanical, electrical stimuli, photo stimulation or bradykinin 
addition that cause Ca2+ rise in cultured astrocytes may contribute to 
neuronal glutamate release, leading to Ca2+ elevation in neurons. 
Additionally, astrocytes cover nerve terminals and can respond to synaptic 
activation [21]. They release synaptically active molecules to synaptic 
clefts, such as glutamate, ATP, adenosine, GABA and D-serine [22]. Release 
of neuroligands from glia is known as gliotransmission. Furthermore, 
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astrocytes can release growth factors, cytokines like tumor necrosis factor 
alpha (TNF-α), neuroactive steroids such as estradiol, progesterone and 
metabolites that can effect synapses [22]. Astrocytes are actively involved 
in the processing the information flow along pre-synaptic and post-synaptic 
neurons. They respond to synaptic activity, regulate synaptic transmission 
and synaptic plasticity, display tripartite means of synaptic information flow. 
 
 
 
Figure 4. Glutamate-glutamine and GABA-glutamine shuttle (image taken from 
[20]). 
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5. FUNDAMENTS OF NEUROGLIA 
 
5.1. RADIAL GLIA 
 
Earlier research depicted radial glia as the cells with long processes 
that extend through apicobasal axis of neuroepithelium and that direct 
neuronal migration. Later in the development, they differentiate into both 
neuronal and glial lineages. 
At the beginning of 2000s, the knowledge about radial glia increased 
when Merkle and Tramontin tested the hypothesis that radial glia produce 
adult NSC in the mouse SVZ using a Cre-lox technique to label striatal radial 
glia at P0. They investigated maturation of SVZ and found that at P0, the 
striatal ventricular zone (VZ) was comprised mainly from radial glia and a 
few immature ependymal cells. They stained the cells for GFAP and RC2 in 
the period from P0 to P60 and confirmed that loss of radial cells correlates 
to the appearance of astrocytes. From P4 to P10, radial glia developed into 
striatal and SVZ astrocytes, while at P4 neuroblasts were present in SVZ 
and rostral migratory stream. At P10 in the olfactory bulb, granular and 
periglomerular neurons were spotted. Ependymal cells were found in lateral 
ventricular wall and oligodendrocytes in the striatum and corpus callosum. 
Adult neural stem cells, type II astrocytes and transit-amplifying cells were 
confirmed. These cells were present up to P150 mice, confirming that radial 
glia act as neural progenitor cells during development, as well as neural 
stem cells in adult CNS [23]. 
During the early developmental stages of CNS, radial glia can be 
immunohistochemically marked (Figure 5) with antibodies against 
Vimentin, Nestin, WT1, Pax6, SOX2, HES1 and HES5, TN-C and N-cadherin, 
GFAP, GLAST, BLBP [24] [25]. While Vimentin and Nestin are more selective 
and specific for radial glia, WT1 stains other precursor cells. Glial fibrillary 
acidic protein (GFAP), astrocyte-specific glutamate transporter (GLAST) and 
BLBP are expressed in both radial glia and astrocytes. Nestin is expressed 
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both in NSC and radial glia [26], while intermediate filament proximal 
protein RC2 is unique antigen expressed only by radial glia [16]. 
 
 
 
 
Figure 5. Immunohistochemistry of postnatal (P18) opossum spinal cord radial 
glia stained for GFAP (left column), GFAP and DAPI (right column). A-B Radial glia 
in ventral column of spinal cord. C-D Radial glia in lateral column of spinal cord. In 
both spinal cord locations, radial glia show bipolar morphology. Some cells show 
branching, implicating the developing astroglia (inset). Scale bar, 50µm. (Source: 
Laboratory for Molecular Neurobiology, neuroreg.uniri.hr ). 
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5.2. NG2 CELLS 
 
NG2 glia, synantocytes or polydendrocytes, were relatively recently 
discovered (in 1980s). They are CNS parenchymal cells, specific for 
expressing a single membrane-spanning chondroitin sulphate proteoglycan 
NG2 with large extracellular domain and short cytoplasmic tail [27]. 
Cells positive for NG2 are multipotent progenitors present in 
developing and mature CNS. Small stellate cells positive for NG2 are 
different from neurons and astrocytes. Fraction of those cells are positive 
for GFAP, but later in their development, they become negative for NG2. 
Other portion of the NG2-positive stellate cells have ganglioside receptors, 
also present in neurons, on which the tetanus toxin binds. These neurons 
lose the expression of NG2 once they are fully developed. Therefore, NG2+ 
cells show properties of both neurons and glia, explaining the origin of their 
name [28]. 
NG2 glia from early postnatal rat optic nerves have shown potential 
to reprogram into multipotent stem cells. Cultivation of cells required fetal 
calf serum (FCS) or bone morphogenetic proteins (BMPs) and the resulting 
cells were population of type II astrocytes. Further treatment with basic 
fibroblast growth factor (bFGF) gave rise to neurospheres, which contained 
neural stem cells. Neurospheres may differentiate into neurons, astrocytes 
and oligodendrocytes [29]. 
NG2 cells express platelet-derived growth factor alpha (PDGFRα), as 
well as antigens on the surface, A2B5 and NG2 proteoglycan [25]. 
Localization of NG2 cells with antibodies has shown opulent NG2 distribution 
throughout the whole brain and spinal cord, which led to NG2 known as the 
“fifth neural cell type” [30] [27] [31] [32]. This claim put NG2 cells to 
separate category next to astrocytes and oligodendrocytes, microglia and 
neurons. 
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5.2.1. NG2 IN NEURAL NETWORKS 
 
NG2 and astrocytes hold similarities. Morphologically, both cell types 
are stellate, but they diverge in structure and arborisation of their 
processes. NG2 cell processes are finer and branch closer to the body, while 
astrocyte have higher density of processes and more abundant collateral 
processes [8]. 
NG2 domains are similar to astrocyte domains. NG2 domains 
interconnect with astrocytic domains to communicate. They diverge in 
interactions with neurons, which suggests individual communication with 
neural networks [8]. For instance, astrocytes uptake glutamate at 
synapses, but NG2 do not because they lack glutamate transporters. On the 
other hand, both cell types express AMPA-type glutamate receptors [33]. 
Receptors recognize neural activity and result in elevation of intracellular 
calcium levels [8]. 
NG2 associate with neurons at axons, Ranvier nodes and near 
synapses [8]. NG2 glia in hippocampus obtain synaptic input from neurons 
[34]. Glutamatergic and GABAergic synaptic communication amid NG2 and 
neurons was found in cerebellum and cerebral cortex [35]. Additionally, in 
the corpus callosum were found physical synapses amid NG2 and 
unmyelinated axons [36]. 
 
 
5.2.2. NG2 AND GLIAL SCAR 
 
Defensive mechanism of glial cells to CNS injury is to proliferate and 
form glial scar. Glial scar acts as biochemical and physical barrier between 
damaged and healthy tissue. Astrocytes form glial scar with help of other 
myelin-associated cells. Following the damage at lesion site, number of NG2 
positive cells rapidly raises (Figure 6) [10]. 
In vitro studies have shown that neurons avoided surface that was 
coated in NG2 proteoglycan. The neurite outgrowth decreased when NG2 
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was present in the substrate [37]. This shows that NG2 contributes to the 
formation of the barrier that inhibits axonal regrowth. 
 
 
Figure 6. Following the injury to adult rat cerebellum tissue, NG2 cells arrive to 
lesion site. Tissue was labeled with anti-NG2 at different days. C-D show NG2 cell- 
formed glial scar (image taken and modified from [38]). 
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5.3. OLIGODENDROCYTES 
 
Oligodendrocytes are CNS glial cells that produce myelin sheath that 
enwraps axons. Signal transduction is necessary for the proper function of 
the brain. Evolutionally, organisms have developed in different ways to 
increase the transduction of action potential and communication between 
neurons and effector organs. In invertebrates, the diameter of axons grew 
in more evolved species. Larger axons enable faster propagation of action 
potential. However, by increase of the brain size and quantity of neurons, 
larger neurons are not the most favorable option. This led to development 
of myelin sheath in vertebrates [2]. Oligodendrocytes spirally wrap the 
neuronal axon segments to provide structural stability and insulation. They 
are also called internodes because at each end of myelin segment are 
Ranvier nodes. The fatty layer, myelin sheath, allows faster velocity of 
nerve impulses and minimizes the axonal diameter in the CNS connective 
tracts [2]. 
Oligodendrocytes undergo specific stepwise morphological and 
functional changes from progenitors to myelinating oligodendrocytes. 
Specific markers have been identified for each maturation step (Figure 7). 
NG2 migrate to their final position according to signals such as PDGFRα, 
fibroblast growth factor (FGF), hepatocyte growth factor, chemotropic 
molecule netrins, secreted semaphorins, chemokine CXCL1, among others. 
Migration process is under control by extracellular matrix proteins and cell 
surface molecules [39]. When NG2 differentiate into oligodendrocytes, 
PDGFRα, A2B5 and NG2 proteoglycan get downregulated. Migrating NG2 
and mature oligodendrocytes express Olig genes. Olig1 and Olig2 are basic 
helix-loop-helix (bHLH) transcription factors, known for oligodendrocyte 
specification, differentiation, maturation and myelination. Olig1 induces 
abundance of NG2 expressing cells [40]. Myelin-oligodendrocyte 
glycoprotein (MOG) is used to detect maturation of oligodendrocytes. It is 
expressed on oligodendrocyte surface 1-2 days after the rest of 
oligodendrocyte markers [41]. Myelin basic protein (MBP) also marks 
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mature oligodendrocytes. It is a structural compound of myelin, which is 
largely present at the beginning of myelination [42]. Furthermore, 
oligodendrocyte-specific protein (OSP) is also present in oligodendrocytes 
and opulent in myelin [43]. Finally, transcription factor group SoxE induces 
precursors to differentiate into oligodendrocytes. SoxE group involves Sox8, 
Sox9 and Sox10 transcription factors, where each has distinct role in 
oligodendrocyte fate. Sox9 is important for oligodendrocyte specification 
and Sox10 guides neural stem cells differentiation into oligodendrocytes and 
regulates expression of MBP and PDGFRα [44]. 
 
 
 
 
Figure 7. Oligodendrocyte markers during development (image taken from [25]). 
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5.4. ASTROCYTES 
 
The second most abundant population of glial cells in the central 
nervous system, astrocytes, are highly heterogeneous cells and tightly 
integrated in neural networks. They sustain neurotransmission, metabolic, 
water and ion homeostasis and help to form and control the blood-brain 
barrier. They also contribute to sleep cycle regulation, female sexual 
maturity and other [2]. 
Astrocytes are present throughout the healthy CNS. Protoplasmic 
astrocytes are situated in grey matter and do not overlap between each 
other. Most of the distal processes interlock and form gap junctions [45]. 
The protoplasmic fine processes are evenly distributed in grey matter. 
Territorial domains of protoplasmic astrocytes are called neurovascular or 
gliovascular units depending on the type of cells that predominantly appear 
in. Both protoplasmic and fibrillary astrocyte processes are in contact with 
Ranvier nodes. Membranes of the astroglia are connected to neighboring 
capillaries through an astroglial perivascular process. Astrocytes initiate 
contact and thereby provide for morphological integration of neuronal 
elements within the neurovascular units [2]. 
In pathological conditions, astrocytes can become reactive. After an 
injury or distress of the CNS, astrocyte quantity increases greatly, while 
neuronal quantity recedes. This phenomenon is called astrogliosis and is 
accompanied by morphological changes that contribute to formation of scar 
tissue [46]. 
Heterogeneity in astroglial cell group is a result of their diversity and 
complexity, leading to different functions and potential for specialization. 
Astrocyte cell group, according to Parpura and Verkhratski, can be extended 
into fibrous, protoplasmic astrocytes, but also Müller glia, Bergmann glia, 
tanycytes, pituicytes, perivascular, marginal and velate astrocytes. Humans 
and hominid species have a few more unique astrocyte types. Moreover, 
they claim that radial glia, ependymal cells, choroid plexus cells and retinal 
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pigment epithelial cells also belong to astrocyte category (Figure 1A) [2]. 
Other researchers like Wolburg, Mack and Reichenbach oppose the claims, 
by categorizing ependymocytes, choroid plexus cells, tanycytes, Mϋller cells 
and retinal pigment epithelial cells as a glial subtype of ependymal cells. 
They support their opinion on morphology and contacts of the cell processes 
[47]. 
 
 
5.4.1. HUMAN- AND PRIMATE-SPECIFIC ASTROCYTES 
 
Human cortex comprises of several subtypes of astroglia that are not 
present in rodents - interlaminar astrocytes, polarized astrocytes and 
varicose projection astrocytes [14]. 
Interlaminar astrocytes have spheroid cell bodies and very long 
unbranched processes, which end in the neuropil or on the capillaries. While 
function is still studied, research has shown that their long processes 
upkeep calcium waves in humans, integrate cortical column activity and 
serve as non-synaptic pathway for long-distanced signaling [48]. 
Polarized astrocytes are situated deep in the cortex. They have long, 
unbranched processes or processes with one branch. Cell morphology is 
similar to neurons, but they show extent GFAP labelling. They are unipolar 
and show bare synaptic contacts, serve as long-distance communication 
pathway across cortex [48]. 
Varicose projection astrocytes have shorter and straighter processes 
than protoplasmic astrocytes. They exhibit up to five long processes that 
evenly divide varicosities. Their function still needs to be revealed [49]. 
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5.4.2. MOLECULAR MARKERS 
 
Identification and characterization of astrocytes in healthy and 
pathological conditions is often done with immunohistochemical techniques. 
Astrocytes express GFAP (Figure 8), which belongs to group of intermediate 
filament proteins that assist to architectural functions of astrocytes. GFAP 
labels most reactive astrocytes at pathological lesions and is essential in 
astrogliosis [50]. However, GFAP does not label all non-reactive astrocytes 
present in healthy tissue [46]. It also does not distinguish the fibrous from 
protoplasmic astroglia and is not exclusive to astrocytes as it can be 
expressed in various tissues. GFAP labels main stem branches, but is not 
present in fine processes [51]. Immunohistochemical staining with GS and 
S100β is also a method of identifying astrocytes. S100β protein localizes in 
both the nucleus and the cytoplasm [52]. It is expressed in mature 
astrocytes which ensheath blood vessels, but also in ependymal cells [53]. 
GS is an enzyme that is present in astrocytes and used in glutamate to 
glutamine conversion. Sox9 marker has recently been used for identification 
of astrocytes. It is expressed in astrocyte nuclei in adult brain outside of the 
neurogenic regions [54]. Even though astrocytes can be labelled with 
various markers, not many of them are specific for astrocytes. Identification 
of astrocytes should be confirmed by multiple-staining method. 
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Figure 8. Immunohistochemistry of neonatal (P0) rat spinal cord astrocytes 
stained for GFAP (left column) and S100β (middle column). A-F In resting 
astrocytes these two markers don’t overlap while in reactive phenotype (24 hours 
after dissection, G-L) GFAP expression is upregulated of and co-expressed with 
S100β. Scale bar, 50µm. (Source: Laboratory for Molecular Neurobiology, 
neuroreg.uniri.hr ). 
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5.5. EPENDYMAL CELLS 
 
Ependymal cells are considered as separate macroglia cell type 
derived from neuroectoderm. The choroid plexus cells, the ependymal cells 
and the parenchyma form cerebrospinal fluid (CSF) in the cerebral 
ventricles. The numerous cilia of ependymal cells spread into the ventricular 
cavities and move systematically to generate a CSF stream. Along the 
stream, they filter molecules and transport the debris. Ependymal cells form 
barrier to protect the CNS from harmful molecules in the CSF [7]. 
Radial glia cells are ependymal cell progenitors, which was confirmed 
by fluorescent tagging of radial cells. Double-labelling with radial glia 
marker GLAST and ependymal cell marker S100β at P2 and P6 has shown 
that nearly all cells at P2 expressed GLAST, while by P6 most expressed 
S100β, meaning radial glia differentiate into ependymal cells [7]. 
Vimentin, intermediate filament protein is expressed in fibroblasts, 
radial glia, astrocytes and ependymal cells. It is expressed earlier than GFAP 
in the cell development, which is why it is used as early glia differentiation 
marker. GFAP is also a marker of ependymal cells, as well as astroglia [55]. 
In ependymal cells, GFAP is lightly expressed, in contract to vivid expression 
in astrocytes. Ependymal cells can also be stained with S100β marker, 
which is primary astrocytic marker (Figure 9). 
Ependymal cells and astrocytes are rich in water transport protein 
aquaporin 4. They are abundant in the latero-basal domains and lightly in 
the apical domain in the ependymal cells, while in parenchymal astrocytes 
they are located in the vascular feet [56]. The protein caveolin-1 is an 
endocytosis-linked protein present both in ependymal cells and in reactive 
astrocytes and it has similar roles. In ependymal cells, it reuptakes some 
molecules from CSF and in astrocytes it serves for endocytosis and sorting 
molecules [56]. 
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Figure 9. Immunohistochemistry of neonatal (P0) rat spinal cord central canal for 
ependymal cells stained with GFAP (A), DAPI (B), S100β (C) and merged image 
with all markers (D). Ependymal cells show lighter GFAP expression than 
astrocytes. Comparing the inset from image A to number of cell nuclei stained in 
the same position (B), it is likely that ependymal cells are present greatly around 
the central canal. C shows that both astrocytes and ependymal cells can be stained 
with S100β. Scale bar, 50µm. (Source: Laboratory for Molecular Neurobiology, 
neuroreg.uniri.hr). 
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5.6. MICROGLIA 
 
Microglial cells are derived from their progenitors situated in extra- 
embryonic yolk sac. They colonize neuroepithelium around E9.5. 
Embryonically-derived microglia proliferate during late gestation, post-natal 
development and in pathological conditions due to inflammation in 
adulthood (Figure 10) [57]. Microglia are part of the innate immune system 
and act as first responders to the CNS injury. They also have a role in plastic 
remodeling of neuronal tissue. Microglia release TNF-α, provide support to 
cells and assist synaptic repair. TNF-α signals lymphocytes and 
macrophages and promotes production of oligodendrocytes [58]. 
 
 
Figure 10. Microglia homeostasis and brain development (image taken from 
[57]). 
 
Microglia at early developmental stages have amoeboid shape. They 
use blood vessels and white matter tracts to propagate through the CNS. 
After some point in development, microglia assume more branched 
morphology with compact bodies and fine processes [2]. 
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Resting microglia in the healthy CNS have tiny soma and long and 
branched processes [59]. Their processes extend and cover the tissue 
looking for potential danger. They exchange information with glial cells and 
neurons by surface molecules expressed on the cells. These molecules on 
microglia are mostly receptors, which recognize the infection, but also bind 
ligands on healthy cell membranes. Ligands such as CD200 on neurons, 
astroglia and oligodendroglia, and CX3CL1 and CD47 on neurons bind to 
microglial receptors and keep them quiescent. Receptor for colony 
stimulating factor1 (CSFR1) is also expressed on microglia membrane and 
is important for cell development and survival [60]. 
When Toll-like receptors (TLR), scavenger receptors and other 
cytokine and chemokine receptors detect infection, ischemia, trauma or 
impaired homeostasis, microglia retract their processes, increase mobility 
and undergo activation. Activation makes them become amoeboid, like at 
early developmental stages, and release protective and/or proinfammatory 
factors. They recruit other immune cells and microglia at the lesion site. 
Microglia can proliferate in pathological conditions. They perform 
phagocytosis and clear out microbes, injured cells and debris. Moreover, 
they present antigens to T lymphocytes and evoke adaptive immune 
responses [61] [62] [2] [63]. 
Microglia identification is still challenging because they express 
antigens that other cell types express as well. Microglia and macrophages 
both express CD11b, CD68; lymphocytes and microglia LCA, LN-1 and 
microglia and oligodendrocytes both express GD3 [64]. Marker that is 
specific for microglia, yet its function remains to be explored, is 
transmembrane protein 119 (Tmem119). This marker is not expressed on 
macrophages and other immune or neural cells [65]. Furthermore, 
microglia are very often identified by staining with calcium binding adaptor 
molecule 1, Iba1 (Figure 11) [66]. It is expressed in microglia and 
macrophages and has functional role in membrane ruffling and the 
phagocytosis [67]. 
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Figure 11. Immunohistochemistry of postnatal (P19) opossum cortex microglia 
stained for Iba1. Image B shows enlarged section of inset in image A. It is visible 
that microglia is not in one focal line, proving that microglia surrounds neighboring 
cells communicating and scavenging for distress. Scale bar, 50µm. (Source: 
Laboratory for Molecular Neurobiology, neuroreg.uniri.hr ). 
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6. DISCUSSION 
 
Neuroscience is a multidisciplinary scientific field that studies the 
nervous system. It aims to discover the functions of the nervous system, 
including how information is spread and integrated to execute complex 
cognitive and motor tasks, memory, perception, consciousness, behavior 
and learning. The huge advances in technology made possible to examine 
the cell structure and morphology, such as the invention of the super- 
resolution microscope and development of more sophisticated staining 
techniques. Neuronal networks and synapses were revealed, as well as the 
action potential that allowed fast spreading of the information. 
Even though neurons and glial cells were described at the early 19th 
century, physiological study of neuroglia began 50 years later. As the 
neuroglia were considered to be acellular connective tissue of the brain, 
they were overshadowed by neurons and left out from the majority of 
researches until it was discovered that glia gave nervous system its form 
and held it together. More focus was directed to glia when the researchers 
started unveiling that glia have important roles in healthy brain function, 
synapses, behavior and in neurological disorders. 
Glia classification presents a challenge and opposing views come from 
different researchers. In the first half of 20th century, neuroglia were divided 
into astroglia, oligodendroglia and microglia. In 1980s another glial 
subtype, the NG2 glia have been proposed [8]. NG2 glia have multiple roles 
in the CNS: they receive synaptic inputs from neurons, form glial scar and 
inhibit axonal growth and remyelinate axons (similar to astrocytes). During 
gliogenesis, NG2 cells develop into immature pro-oligodendrocytes that 
have numerous processes. They further develop into mature 
oligodendrocytes that have membrane sheaths and finally into myelinating 
oligodendrocytes, which is the reason some researchers put NG2 glia in the 
category of oligodendrocytes. Each oligodendrocyte maturation step has 
specific markers, which determine their development. However, terms like 
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NG2, OPC and pro-oligodendrocyte get associated as well as mature non- 
myelinating and myelinating oligodendrocytes. Therefore, the unambiguous 
distinction between NG2 and oligodendrocytes (and/or their precursors) is 
still missing. However, apart from being oligodendrocyte precursor cells, 
NG2 glia have shown potential to reprogram and become multipotent stem 
cells (similar to radial glia). NG2 can differentiate into type II astrocytes 
and oligodendrocytes in postnatal rat optic nerve [29]. When treated with 
bFGF they can become neurospheres, which can, in addition to glia, produce 
neurons [29]. 
Furthermore, astroglia have shown that they are extremely 
heterogeneous and in different CNS regions. They adjust to environment, 
express different molecules and preform many diverse functions. Most 
researches examine fibrous and protoplasmic astrocytes, but there are 
plenty of other subtypes of astroglia, whose function is not studied enough. 
Additionally, primates have unique astroglia subtypes, but their function 
remains unexplored and sets questions of functional and regional 
heterogeneity of astrocytes in humans. 
Ependymal cells participate in CSF formation and flow, protection and 
homeostasis of CNS. They have been regarded as astrocytes for their 
plentiful similarities. Both cell types can be labeled with the same markers 
– GFAP, vimentin and S100β. Water transporter aquaporin 4 and 
endocytosis protein caveolin-1 are expressed in both cells and have similar 
functions. But over and above, ependymal cells and astrocytes show various 
differences in morphology and function, proving that identification on the 
sole morphology level tends to be unreliable. 
Radial glia is another example of marker redundancy: common 
markers exist with neuroepithelial cells, as well as astrocytes; such as GFAP, 
GLAST and BLBP in astrocytes and Nestin in neuroepithelial cells. Radial glia 
used to be referred to as a “scaffold” for neuronal migration, but later it 
became evident that they in parallel generate neurons. Furthermore, some 
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researchers still consider radial glia is an astrocyte subtype, while it is clear 
that radial glia is a source for both neuronal and glial lineages. 
Oligodendrocytes happen to be one of the better-characterized glial 
cells, but not all identification markers are oligodendrocyte-exclusive. 
Sox9, a transcription factor vital for oligodendrocyte specification [44] was 
recently used as an exclusive marker for astrocytes in adult mouse brain 
except for ependymal cells and adult neurogenic niches, where SOX9 is also 
expressed by NSC [54]. 
Identification markers for microglia are not that specific as well. 
CD11b, CD68 and Iba1 stain macrophages and GD3 stains 
oligodendrocytes. Microglia also have some similarities with astrocytes. 
They both have some similar functions in synaptic pruning and releasing 
the same factors, such as brain-derived neurotrophic factor (BDNF), glial- 
derived neurotrophic factor (GDNF) and insulin-like growth factor (IGF-1) 
[68]. 
Apart for not being specific and labelling different types of glia, 
markers can cross-react with similar antigens and bind non-specifically, 
bringing interference and additional identification distress. 
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7. CONCLUSION 
 
Glial cells are very diverse contributors to retaining the function of the 
CNS in healthy and pathological conditions. Glia can be divided by their 
origin into macroglia and microglia. Macroglia can further be split into 
astrocytes and oligodendrocytes. Other neuroglia types, ependymal cells 
and NG2 are associated with astrocytes or oligodendrocytes. 
The main basis of glial identification is immunostaining with markers 
for distinct molecules expressed by cells. However, many similar overlaps 
in marker expression can be found between glia. Labeling more glia types 
brings possibilities of misinterpretation, as well as nonspecific binding. 
Furthermore, most markers bind regionally, not labeling the whole cell. In 
addition, some markers are differently expressed during development and 
maturation. Ependymal cells can be labeled with astroglia markers, 
indorsing the belief they are subtype of astrocytes. But taking into 
consideration the function and morphology, ependymal cells undoubtedly 
differ from astrocytes. NG2 cells have been reflected as oligodendrocyte 
precursor cells. However, they have proven the ability to differentiate into 
other glia and neurons suggesting change of view. Microglia have some 
similar functions to astrocytes, yet they have completely different origin 
pathways. 
Apart from identification, the definition and classification of neuroglia 
also remains superficial. While some glia subtypes are well researched, 
there are subtypes that have barely been looked into. Research has mostly 
been conducted on rodents, but this still brings up questions about humans. 
Primate cortex has higher heterogeneity of astrocytes than rodents’. Apart 
from being larger in size, there are unique astrocyte subtypes whose 
function is not known at all. 
Although neuroglia have different morphology, biochemistry and 
functions, they act together and maintain homeostasis of the CNS. They 
each contribute in their specific way and more focus should be aimed 
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towards glia to understand how they interact with each other and how they 
interact with neurons. Cell identification should avoid being solely on the 
expressed molecules or by their function or development. New tools such 
as genetic screening should be considered for exploring the glia evolution. 
Furthermore, functional heterogeneity of cells could be identified with 
discovery of developmental gene regulatory pathways. Also, new 
noninvasive techniques in myelin water imaging (MWI) may be used to 
better characterize and monitor myelin. Genome, proteome and 
metabolome approaches could also help to differentiate glia subtypes. 
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